Literature DB >> 30923289

Effects of Treatment Discontinuation in Clinical Psychopharmacology.

Ross J Baldessarini1, Leonardo Tondo2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30923289     DOI： 10.1159/000497334

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  8 in total

Review 1.  Clinical use of lithium salts: guide for users and prescribers.

Authors:  Leonardo Tondo; Martin Alda; Michael Bauer; Veerle Bergink; Paul Grof; Tomas Hajek; Ute Lewitka; Rasmus W Licht; Mirko Manchia; Bruno Müller-Oerlinghausen; René E Nielsen; Marylou Selo; Christian Simhandl; Ross J Baldessarini
Journal:  Int J Bipolar Disord       Date:  2019-07-22

2.  Discontinuing psychotropic drug treatment.

Authors:  Leonardo Tondo; Ross J Baldessarini
Journal:  BJPsych Open       Date:  2020-02-19

Review 3.  Lithium Treatment Over the Lifespan in Bipolar Disorders.

Authors:  Constantin Volkmann; Tom Bschor; Stephan Köhler
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

4.  Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.

Authors:  Michael P Hengartner; Lukas Schulthess; Anders Sorensen; Adele Framer
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-24

5.  Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA.

Authors:  Michael P Hengartner; Martin Plöderl
Journal:  Ther Adv Psychopharmacol       Date:  2021-08-10

6.  Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditions.

Authors:  Joanna Moncrieff; Janus Christian Jakobsen; Max Bachmann
Journal:  BMJ Evid Based Med       Date:  2021-09-23

7.  Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials.

Authors:  Zainab Nabi; Jacki Stansfeld; Martin Plöderl; Lisa Wood; Joanna Moncrieff
Journal:  Epidemiol Psychiatr Sci       Date:  2022-09-16       Impact factor: 7.818

8.  Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.

Authors:  Anne Le Moigne; Maurizio Fava; John Csernansky; John W Newcomer; James Graham
Journal:  J Clin Psychopharmacol       Date:  2021 Jan-Feb 01       Impact factor: 3.118
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.